{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:59:23Z","timestamp":1768521563704,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":475,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.banm.2020.09.036","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:07:20Z","timestamp":1600427240000},"page":"1000-1009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nouveaux aspects de la lutte contre la rage"],"prefix":"10.1016","volume":"204","author":[{"given":"H.","family":"Bourhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.D.","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tarantola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat Rev Dis Primer"},{"issue":"4","key":"10.1016\/j.banm.2020.09.036_bib0390","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"17","key":"10.1016\/j.banm.2020.09.036_bib0395","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.vaccine.2019.03.037","article-title":"Avoiding preventable deaths: the scourge of counterfeit rabies vaccines","volume":"37","author":"Taylor","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0400","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152611795768079","article-title":"Human rabies encephalitis prevention and treatment: progress since pasteurs discovery","volume":"11","author":"Dacheux","year":"2011","journal-title":"Infect Disord Drug Targets"},{"issue":"8","key":"10.1016\/j.banm.2020.09.036_bib0405","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1099\/jgv.0.001269","article-title":"Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS","volume":"100","author":"Smith","year":"2019","journal-title":"J Gen Virol"},{"key":"10.1016\/j.banm.2020.09.036_bib0410","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0415","doi-asserted-by":"crossref","first-page":"569","DOI":"10.20506\/rst.37.2.2825","article-title":"Rabies: a medical perspective","volume":"37","author":"Jackson","year":"2018","journal-title":"Rev Sci Tech"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/cjn.2015.331","article-title":"Critical appraisal of the milwaukee protocol for rabies: this failed approach should be abandoned","volume":"43","author":"Zeiler","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"10.1016\/j.banm.2020.09.036_bib0425","first-page":"1934e8","article-title":"Structural elucidation of viral antagonism of innate immunity at the STAT1\u00a0interface","volume":"29","author":"Hossain MdA","year":"2019","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.banm.2020.09.036_bib0430","doi-asserted-by":"crossref","first-page":"e1006041","DOI":"10.1371\/journal.ppat.1006041","article-title":"Large-scale phylogenomic analysis reveals the complex evolutionary history of rabies virus in multiple carnivore hosts","volume":"12","author":"Troupin","year":"2016","journal-title":"PLOS Pathog"},{"issue":"11","key":"10.1016\/j.banm.2020.09.036_bib0435","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1371\/journal.pntd.0000839","article-title":"Rabies, still neglected after 125\u00a0years of vaccination","volume":"4","author":"Bourhy","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0440","first-page":"e47","article-title":"Emerging concepts of data integration in pathogen phylodynamics","volume":"66","author":"Baele","year":"2017","journal-title":"Syst Biol"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0445","doi-asserted-by":"crossref","first-page":"401","DOI":"10.20506\/rst.37.2.2810","article-title":"Genomic sequencing, evolution and molecular epidemiology of rabies virus","volume":"37","author":"Brunker","year":"2018","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.banm.2020.09.036_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.03.023","article-title":"Successful strategies implemented towards the elimination of canine rabies in the Western Hemisphere","volume":"143","author":"Velasco-Villa","year":"2017","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0455","doi-asserted-by":"crossref","first-page":"305","DOI":"10.20506\/rst.37.2.2804","article-title":"Introduction history of rabies control by vaccination","volume":"37","author":"Banyard","year":"2018","journal-title":"Rev Sci Tech Int"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0460","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1371\/journal.pntd.0000626","article-title":"The feasibility of canine rabies elimination in Africa: dispelling doubts with data","volume":"4","author":"Lembo","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"13","key":"10.1016\/j.banm.2020.09.036_bib0465","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.vaccine.2017.02.014","article-title":"Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings","volume":"35","author":"Lavan","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0470","doi-asserted-by":"crossref","first-page":"559","DOI":"10.20506\/rst.37.2.2824","article-title":"Proof of concept of mass dog vaccination for thecontrol and elimination of canine rabies","volume":"37","author":"Cleaveland","year":"2018","journal-title":"Rev Sci Tech Int"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0475","doi-asserted-by":"crossref","first-page":"741","DOI":"10.20506\/rst.37.2.2837","article-title":"Global rabies control: the role of international organisations and the Global Strategic Plan to eliminate dog-mediated human rabies","volume":"37","author":"Abela-Ridder","year":"2018","journal-title":"Rev Sci Tech Int"},{"issue":"4","key":"10.1016\/j.banm.2020.09.036_bib0480","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/1365-2664.12279","article-title":"The demography of free-roaming dog populations and applications to disease and population control","volume":"51","author":"Morters","year":"2014","journal-title":"J Appl Ecol"},{"issue":"10","key":"10.1016\/j.banm.2020.09.036_bib0485","doi-asserted-by":"crossref","first-page":"e0205884","DOI":"10.1371\/journal.pone.0205884","article-title":"System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa","volume":"13","author":"Chidumayo","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.banm.2020.09.036_bib0490","doi-asserted-by":"crossref","first-page":"A154","DOI":"10.1016\/j.vaccine.2018.11.035","article-title":"The impact of transmission dynamics of rabies control: systematic review","volume":"37","author":"Rattanavipapong","year":"2019","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.banm.2020.09.036_bib0495","doi-asserted-by":"crossref","first-page":"e1001166","DOI":"10.1371\/journal.ppat.1001166","article-title":"Phylodynamics and human-mediated dispersal of a zoonotic virus","volume":"6","author":"Talbi","year":"2010","journal-title":"PLOS Pathog"},{"issue":"4","key":"10.1016\/j.banm.2020.09.036_bib0500","doi-asserted-by":"crossref","first-page":"e1005525","DOI":"10.1371\/journal.ppat.1005525","article-title":"Revealing the micro-scale signature of endemic zoonotic disease transmission in an African urban setting","volume":"12","author":"Bourhy","year":"2016","journal-title":"PLOS Pathog"},{"issue":"421","key":"10.1016\/j.banm.2020.09.036_bib0505","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6984","article-title":"Vaccination of dogs in an African city interrupts rabies transmission and reduces human exposure","volume":"9","author":"Zinsstag","year":"2017","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.banm.2020.09.036_bib0510","doi-asserted-by":"crossref","first-page":"e1006554","DOI":"10.1371\/journal.pcbi.1006554","article-title":"A graph-based evidence synthesis approach to detecting outbreak clusters: an application to dog rabies","volume":"14","author":"Cori","year":"2018","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.banm.2020.09.036_bib0515","series-title":"WHO Expert Consultation on Rabies. Second Report","article-title":"WHO Technical Expert Series","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.banm.2020.09.036_bib0520","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1038\/srep18232","article-title":"Heterogeneity in the spread and control of infectious disease: consequences for the elimination of canine rabies","volume":"5","author":"Ferguson","year":"2015","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.banm.2020.09.036_bib0525","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/molbev\/msx176","article-title":"Using viral gene sequences to compare and explain the heterogeneous spatial dynamics of virus epidemics","volume":"34","author":"Dellicour","year":"2017","journal-title":"Mol Biol Evol"},{"issue":"18","key":"10.1016\/j.banm.2020.09.036_bib0530","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1111\/mec.15222","article-title":"Using phylogeographic approaches to analyse the dispersal history, velocity and direction of viral lineages\u00a0\u2013\u00a0Application to rabies virus spread in Iran","volume":"28","author":"Dellicour","year":"2019","journal-title":"Mol Ecol"},{"issue":"3","key":"10.1016\/j.banm.2020.09.036_bib0535","doi-asserted-by":"crossref","first-page":"e1000053","DOI":"10.1371\/journal.pbio.1000053","article-title":"Transmission dynamics and prospects for the elimination of canine rabies","volume":"7","author":"Hampson","year":"2009","journal-title":"PLOS Biol"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0540","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1746-6148-8-236","article-title":"Domestic dog demographic structure and dynamics relevant to rabies control planning in urban areas in Africa: the case of Iringa, Tanzania","volume":"8","author":"Gsell","year":"2012","journal-title":"BMC Vet Res"},{"issue":"5","key":"10.1016\/j.banm.2020.09.036_bib0545","doi-asserted-by":"crossref","first-page":"e0008317","DOI":"10.1371\/journal.pntd.0008317","article-title":"Long-range movements coupled with heterogeneous incubation period sustain dog rabies at the national scale in Africa","volume":"14","author":"Colombi","year":"2020","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0550","article-title":"Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure","volume":"2","author":"Tarantola","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.banm.2020.09.036_bib0555","doi-asserted-by":"crossref","first-page":"A88","DOI":"10.1016\/j.vaccine.2018.10.103","article-title":"Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines","volume":"37","author":"Tarantola","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0560","unstructured":"Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies [Internet]. [cit\u00e9 3\u00a0mai 2020]. Disponible sur: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5902a1.htm."},{"issue":"3","key":"10.1016\/j.banm.2020.09.036_bib0565","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1\u00a0schedule application for postexposure treatment","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0570","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/infdis\/140.2.176","article-title":"Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon","volume":"140","author":"Nicholson","year":"1979","journal-title":"J Infect Dis"},{"issue":"8437","key":"10.1016\/j.banm.2020.09.036_bib0575","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(85)92367-0","article-title":"Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis","volume":"325","author":"Warrell","year":"1985","journal-title":"Lancet"},{"issue":"8694","key":"10.1016\/j.banm.2020.09.036_bib0580","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","article-title":"Postexposure prophylaxis for rabies with antiserum and intradermal vaccination","volume":"335","author":"Chutivongse","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.banm.2020.09.036_bib0585","doi-asserted-by":"crossref","first-page":"A107","DOI":"10.1016\/j.vaccine.2019.01.041","article-title":"Rabies post-exposure prophylaxis: a systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course","volume":"37","author":"Kessels","year":"2019","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.banm.2020.09.036_bib0590","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0264-410X(95)00213-K","article-title":"What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?","volume":"14","author":"Khawplod","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0595","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2018.10.054","article-title":"Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003\u20132014","volume":"37","author":"Tarantola","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.banm.2020.09.036_bib0600","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1473-3099(19)30311-1","article-title":"A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study","volume":"19","author":"Cantaert","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"37","key":"10.1016\/j.banm.2020.09.036_bib0605","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018\u00a0\u2013\u00a0Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.banm.2020.09.036_bib0610","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jtm.12228","article-title":"Rabies vaccine and rabies immunoglobulin in cambodia: use and obstacles to use","volume":"22","author":"Tarantola","year":"2015","journal-title":"J Travel Med"},{"key":"10.1016\/j.banm.2020.09.036_bib0615","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.vaccine.2019.01.065","article-title":"A social justice perspective on access to human rabies vaccines","volume":"37","author":"Wentworth","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0620","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2018.11.004","article-title":"Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline","volume":"37","author":"Sparrow","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0625","first-page":"A85","article-title":"The WHO position on rabies immunization\u00a0\u2013\u00a02018\u00a0updates","volume":"37","author":"O\u2019Brien","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S0006297918010017","article-title":"Recombinant monoclonal antibodies for rabies post-exposure prophylaxis","volume":"83","author":"Ilina","year":"2018","journal-title":"Biochem Mosc"},{"issue":"3","key":"10.1016\/j.banm.2020.09.036_bib0635","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cid\/cix791","article-title":"Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2\/3, randomized, single-blind, noninferiority, controlled study","volume":"66","author":"Gogtay","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.banm.2020.09.036_bib0640","unstructured":"Serum Institute of India PVT. LTD. Rabishield [Internet]. [cit\u00e9 1\u00a0mai 2020]. Disponible sur: https:\/\/www.seruminstitute.com\/product_ind_rabishield.php#prosub-ind."},{"key":"10.1016\/j.banm.2020.09.036_bib0645","series-title":"Randomized, multi-centric, open-label, comparator-controlled study to evaluate the efficacy and safety of RABIMABs administered in conjunction with Vaxirab N for post-exposure prophylaxis in patients following potential rabies exposure","author":"The Clinical Trials Registry India (CTRI)","year":"2017"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0650","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/tropicalmed5010031","article-title":"In vivo efficacy of SYN023, an anti-rabies monoclonal antibody cocktail, in post-exposure prophylaxis animal models","volume":"5","author":"Chao","year":"2020","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"10.1016\/j.banm.2020.09.036_bib0655","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"De Benedictis","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-14398-7","article-title":"Structure of the prefusion-locking broadly neutralizing antibody RVC20\u00a0bound to the rabies virus glycoprotein","volume":"11","author":"Hellert","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.banm.2020.09.036_bib0665","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/tropicalmed2030048","article-title":"In vivo efficacy of a cocktail of human monoclonal antibodies (CL184) against diverse North American bat rabies virus variants","volume":"2","author":"Franka","year":"2017","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"10.1016\/j.banm.2020.09.036_bib0670","first-page":"399","article-title":"Development of recombinant human monoclonal antibody cocktail for post-exposure rabies prophylaxis","volume":"32","author":"Sun","year":"2016","journal-title":"Bing Xue Bao Chin J Virol"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0675","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tibtech.2018.05.014","article-title":"The increasingly human and profitable monoclonal antibody market","volume":"37","author":"Grilo","year":"2019","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.banm.2020.09.036_bib0680","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.coche.2018.01.007","article-title":"Engineering therapeutic antibodies to combat infectious diseases","volume":"19","author":"Wagner","year":"2018","journal-title":"Curr Opin Chem Eng"},{"issue":"12","key":"10.1016\/j.banm.2020.09.036_bib0685","first-page":"1008","article-title":"Anticorps monoclonaux en infectiologie\u00a0\u2013\u00a0Des nouveaux partenaires dans l\u2019arsenal th\u00e9rapeutique","volume":"35","author":"Desoubeaux","year":"2019","journal-title":"Med Sci"},{"key":"10.1016\/j.banm.2020.09.036_bib0690","doi-asserted-by":"crossref","first-page":"A73","DOI":"10.1016\/j.vaccine.2018.10.012","article-title":"Global characteristics of the rabies biologics market in 2017","volume":"37","author":"Ives","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0695","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","article-title":"Rabies: changing prophylaxis and new insights in pathophysiology","volume":"31","author":"Ugolini","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.banm.2020.09.036_bib0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2018.12.009","article-title":"Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses","volume":"35","author":"Du Pont","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0705","doi-asserted-by":"crossref","first-page":"673","DOI":"10.20506\/rst.37.2.2832","article-title":"Antivirals for human use against rabies and prospects for their future application","volume":"37","author":"Koraka","year":"2018","journal-title":"Rev Sci Tech Int"},{"issue":"33","key":"10.1016\/j.banm.2020.09.036_bib0710","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1016\/j.vaccine.2017.12.051","article-title":"The path towards effective antivirals against rabies","volume":"37","author":"Jochmans","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0715","article-title":"Ribavirin has an in vitro antiviral effect in rabies virus infected neuronal cells but fails to provide benefit in experimental rabies in mice","author":"Appolinario","year":"2013","journal-title":"J Virol Antiviral Res"},{"key":"10.1016\/j.banm.2020.09.036_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.03.011","article-title":"Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus","volume":"154","author":"Anindita","year":"2018","journal-title":"Antiviral Res"},{"issue":"33","key":"10.1016\/j.banm.2020.09.036_bib0725","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1016\/j.vaccine.2017.10.109","article-title":"Re-evaluating the effect of Favipiravir treatment on rabies virus infection","volume":"37","author":"Banyard","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.10.016","article-title":"Pyrimethamine inhibits rabies virus replication in vitro","volume":"161","author":"Rog\u00e9e","year":"2019","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.banm.2020.09.036_bib0735","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/v12020177","article-title":"Antiviral ranpirnase TMR-001\u00a0inhibits rabies virus release and cell-to-cell infection in vitro","volume":"12","author":"Smith","year":"2020","journal-title":"Viruses"},{"issue":"33","key":"10.1016\/j.banm.2020.09.036_bib0740","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.vaccine.2018.04.003","article-title":"The effect of combined drugs therapy on the course of clinical rabies infection in a murine model","volume":"37","author":"Smreczak","year":"2019","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.banm.2020.09.036_bib0745","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1016\/j.vaccine.2018.05.066","article-title":"Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin","volume":"37","author":"Marosi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.banm.2020.09.036_bib0750","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijbiomac.2017.05.179","article-title":"Nicotinic acetylcholine receptor alpha 1(nAChR\u03b11) subunit peptides as potential antiviral agents against rabies virus","volume":"104","author":"Sajjanar","year":"2017","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.banm.2020.09.036_bib0755","first-page":"109","article-title":"Assessment of in vivo antiviral potential of datura metel linn. Extracts against rabies virus","volume":"10","author":"Roy","year":"2018","journal-title":"Pharmacogn Res"},{"key":"10.1016\/j.banm.2020.09.036_bib0760","doi-asserted-by":"crossref","first-page":"e12628","DOI":"10.15252\/emmm.202012628","article-title":"A combination of two human monoclonal antibodies cures symptomatic rabies","author":"de Melo","year":"2020","journal-title":"EMBO Mol Med"}],"container-title":["Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001407920305100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001407920305100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:59:30Z","timestamp":1757545170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001407920305100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0001407920305100"],"URL":"https:\/\/doi.org\/10.1016\/j.banm.2020.09.036","relation":{},"ISSN":["0001-4079"],"issn-type":[{"value":"0001-4079","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nouveaux aspects de la lutte contre la rage","name":"articletitle","label":"Article Title"},{"value":"Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.banm.2020.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 l'Acad\u00e9mie nationale de m\u00e9decine. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}